Formulary Monographs [RITONAVIR, 08180808]
|
|
RITONAVIR
|
|
|
|
|
|
HIV PROTEASE INHIBITORS
|
|
|
Not typically used as sole protease inhibitor (PI), but as pharmacokinetic enhancer of other PIs
Indicated in combination with other antiretroviral agents for the treatment of HIV-infection See lopinavir/ritonavir |
|
|
See lopinavir/ritonavir.Increased triglycerides, Diarrhea, Nausea , taste perversion,
|
|
|
Initial dose 300mg twice daily gradually increased by 100mg twice
daily over a period of up to 14 days to a maximum of 600mg twice daily . |
|
|
|
|
|
See lopinavir/ritonavir.
|
|
|
The Centers for Disease Control and Prevention (CDC) and other experts recommend that HIV-infected women not breast-feed infants, regardless of antiretroviral therapy due to the risk of transmitting the virus through breastfeeding.
|
|
|
|